NCT05029791View on ClinicalTrials.gov

Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

November 18, 2031

Study Completion Date

November 18, 2031

Conditions
Melanoma
Interventions
OTHER

Tumor biopsy

2 cutaneous tumor biopsies before treatment initiation (D-28 to D-1) and under treatment (Month 1)

OTHER

Blood sample

1 EDTA blood sample (8mL) before treatment initiation (D-28 to D-1)

Trial Locations (1)

69495

RECRUITING

Service de dermatologie (Bâtiment 1A), Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER